Genmab A/S Interest Receivable
Genmab A/S (GNMSF) had Interest Receivable of $4.00 million as of 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes › Receivables
ifrs-full:InterestReceivable · last filed 2026-02-17
- 2024-12-31: Interest Receivable 133.00M DKK.
- 2023-12-31: Interest Receivable 150.00M DKK.
- 2022-12-31: Interest Receivable 82.00M DKK.
- 2021-12-31: Interest Receivable 37.00M DKK.
DKK
| Period end | Interest Receivable |
|---|---|
| 2024-12-31 | 133.00M DKK 6-K · filed 2025-02-12 |
| 2023-12-31 | 150.00M DKK 6-K · filed 2025-02-12 |
| 2022-12-31 | 82.00M DKK 6-K · filed 2024-02-14 |
| 2021-12-31 | 37.00M DKK 6-K · filed 2023-02-22 |
| 2020-12-31 | 55.00M DKK 6-K · filed 2022-02-16 |
| 2019-12-31 | 34.00M DKK 6-K · filed 2021-02-23 |
| 2018-12-31 | 18.00M DKK 20-F · filed 2020-03-30 |
USD
| Period end | Interest Receivable |
|---|---|
| 2025-12-31 | $4.00M 20-F · filed 2026-02-17 |
| 2024-12-31 | $19.00M 20-F · filed 2026-02-17 |
| 2023-12-31 | $22.00M 20-F · filed 2026-02-17 |